CN1113757A - Sexual function improving agent and its preparing method - Google Patents
Sexual function improving agent and its preparing method Download PDFInfo
- Publication number
- CN1113757A CN1113757A CN 94106772 CN94106772A CN1113757A CN 1113757 A CN1113757 A CN 1113757A CN 94106772 CN94106772 CN 94106772 CN 94106772 A CN94106772 A CN 94106772A CN 1113757 A CN1113757 A CN 1113757A
- Authority
- CN
- China
- Prior art keywords
- sexual function
- sexual
- phentolamine
- preparation
- liquid organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention relates to a medicament containing organic substances, in particular it is a sexual function improving agent capable of curing male and female sexual disfunction and promoting the harmony of man and wife sexual life and its preparation method. Said medicament is a compound external-use spray pigmentum which is made up by combining the Chinese medicines (such as ligustrazine, papaverine, secretio bufonis and laurocapram, etc.) and the Western medicines (such as phentolamine), and is made up by making the above-mentioned effective ingredients pass through such processes of mixing and filtering, etc.. Said invention solves the disadvantages of existent medicine curing male sexual disfunction, such as single application region and therapeutic range, and has the advantages of that said medicine can be jointly used by male and female, and its application mode doesn't injure human body.
Description
The invention belongs to the pharmaceutical preparation that contains the Organic substance batching, be meant a kind of men and women's of being used for the treatment of sexual dysfunction especially, promote sexual function accelerator of couple's sexual life harmony and preparation method thereof.
Lack ideal Therapeutic Method for male sexual disorder both at home and abroad at present, be pure Chinese medicine or pure Western medicine prescription in the similar products at home and abroad, therefore medicine-feeding part and therapeutic domain are subjected to certain restriction, wherein the pure Chinese medicinal preparation flavor is dense, color is heavy, giving property environment brings certain interference, and a kind of preparation can not the men and women be used together, unilaterally improve the libido on the bridegroom's or husband's side only, thereby do not reach the purpose of couple's sexual life harmony, the ICI(penis cavernosa injection that is used for the treatment of sexual impotence) though the Therapeutic Method determined curative effect, but existing easily makes the patient produce the feared state of mind, life-time service easily produces symptoms such as penile induration and priapism, notification number be in 1076116 disclosed treatment male woman's sexual dysfunction medicine and preparation method mainly with Potiria pectinifera (Mukller et Tro Sehel), Asterias amurensis Lutken, 30 multi-flavor medicines such as Aspongopus are concocted through unique technology, can be used for treating decline of the fire from the gate of life, spleen kidney two loses, yin-yang all loss and the sexual impotence that causes, premature ejaculation, seminal emission waits men and women's sexual dysfunction, it is good to have therapeutic effect, nontoxic, advantages such as side effect, but, still exist technical deficiencies such as medicine-feeding part and therapeutic domain are single because of it belongs to pure Chinese medicinal preparation.
The objective of the invention is to provides a kind of sexual function accelerator and preparation method thereof for the deficiency that overcomes prior art, said preparation can adopt Chinese medicine and western medicine to be mixed and make compound preparation, by each drug component through miscible, processing steps such as filtration and adding stabilizing agent are made, but the same usefulness of said preparation men and women, thereby reach the purpose of impelling the couple's sexual life harmony.
The main composition of neutral function promoter of the present invention is:
A kind of sexual function accelerator is characterized in that this sexual function accelerator is included in the phentolamine that dissolves in effective dose in the liquid organic solvent, and wherein the relative weight portion rate of liquid organic solvent and phentolamine is 500-1100: 5-10.
This organic solvent is: liquid organic solvent is a propylene glycol.
Other components of this promoter also have:
Also contain ligustrazine, papaverine, Venenum Bufonis, azone in this sexual function accelerator, the relative weight portion rate ligustrazine of said components: papaverine: Venenum Bufonis: azone is 15-25: 5-20: 0.5-2: 10-50.
Preparation method of the present invention is:
Phentolamine and liquid organic solution is miscible, filter and in filtrate, add stabilizing agent after packing make finished product.
Other processing steps are in the preparation method of the present invention:
Add power 3 described medicines (as ligustrazine, papaverine, Venenum Bufonis, azone) and mix homogeneously in the solution after phentolamine and liquid organic solvent are miscible in proportion, solution behind the mix homogeneously is filtered, in filtrate, add stabilizing agent, make finished product after the packing.
Accompanying drawing of the present invention has:
Fig. 1 is preparation technology's flow chart of the present invention.
Description of drawings:
A wherein: ligustrazine, papaverine, phentolamine, Venenum Bufonis
B: miscible back solution
C, mixing back solution
D, filtrate
E, finished product
1, adds propylene glycol solvent
2, add azone solution
3, filter
4, packing
Fig. 1 has provided preparation technology's flow chart of first embodiment of the present invention.
In conjunction with the accompanying drawings embodiments of the invention are described as follows:
Embodiment 1: with phentolamine: papaverine: ligustrazine: Venenum Bufonis: propylene glycol is 5: 15: 20 by ratio of weight and the number of copies: 1: 519 ratio miscible evenly after, in phentolamine: azone is that 5: 10 ratio adds the azone after-filtration in above-mentioned solution after miscible, adds stabilizing agent (glucose solution as 5%) and packing and make finished product in the filtrate that makes after filtration.
Embodiment 2: with phentolamine: propylene glycol is the miscible even after-filtration of 5: 750 ratio by ratio of weight and the number of copies and adds stabilizing agent (Glucose Liquid as 5%) back packing and make finished product.
This preparation can be the external spray and smears agent, and medicine-feeding part is urethra, vaginal mucosa or Glans penis.
The substantive distinguishing features that the present invention has and significant technological progress are:
1, this preparation can be made into the Chinese and Western medicine compound formulation, wherein Chinese medicinal ingredients have invigorate blood circulation, the effect of promoting circulation of blood, anti-inflammatory, sterilization, Western medicine has the effect of expansion parteriole, and method of administration is to the human zero damage, smear mucous membrane of urethra or glans penis are carried out the external application spray, administration replaces injection Art has been eliminated medication person's psychology, spirit fear and the complication of bringing thus.
2, this preparation is colourless formulation, and the men and women can same usefulness, thereby has overcome the time difference of both sides' sexual drives, makes man and wife's sexual life and property environment more harmonious.
Claims (5)
1, a kind of sexual function accelerator is characterized in that this sexual function accelerator is included in the phentolamine that dissolves in effective dose in the liquid organic solvent, and wherein the relative weight portion rate of liquid organic solvent and phentolamine is 500-1100: 5-10.
2, sexual function accelerator according to claim 1 is characterized in that liquid organic solvent is a propylene glycol.
3, sexual function accelerator according to claim 1, it is characterized in that also containing in this sexual function accelerator ligustrazine, papaverine, Venenum Bufonis, azone, the relative weight portion rate ligustrazine of said components: papaverine: Venenum Bufonis: azone is 15-25: 5-20: 0.5-2: 10-50.
4, a kind of preparation method of sexual function accelerator according to claim 1, it is characterized in that phentolamine and liquid organic solution is miscible, filter and in filtrate, add stabilizing agent after packing make finished product.
5, the preparation method of sexual function accelerator according to claim 4, it is characterized in that adding in proportion in the solution after phentolamine and liquid organic solvent are miscible power 3 described medicines (as ligustrazine, papaverine, Venenum Bufonis, azone) and mix homogeneously, solution behind the mix homogeneously is filtered, in filtrate, add stabilizing agent, make finished product after the packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94106772 CN1113757A (en) | 1994-06-24 | 1994-06-24 | Sexual function improving agent and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94106772 CN1113757A (en) | 1994-06-24 | 1994-06-24 | Sexual function improving agent and its preparing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1113757A true CN1113757A (en) | 1995-12-27 |
Family
ID=5032657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94106772 Pending CN1113757A (en) | 1994-06-24 | 1994-06-24 | Sexual function improving agent and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1113757A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998052569A1 (en) * | 1997-05-19 | 1998-11-26 | Zonagen, Inc. | Combination therapy for modulating the human sexual response |
| CN1082364C (en) * | 1998-06-30 | 2002-04-10 | 刘岩叨 | Skin nutritious agent |
| CN101167879B (en) * | 2007-11-08 | 2010-10-13 | 金城 | Preparation for increasing erection rigidity and prolonging intercourse endurance and condom containing the same |
| CN103705632A (en) * | 2013-12-27 | 2014-04-09 | 孟小斐 | Application of mammary aggregation dispersing tablets in preparation of medicines for treating penis hardening disease |
-
1994
- 1994-06-24 CN CN 94106772 patent/CN1113757A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998052569A1 (en) * | 1997-05-19 | 1998-11-26 | Zonagen, Inc. | Combination therapy for modulating the human sexual response |
| CN1082364C (en) * | 1998-06-30 | 2002-04-10 | 刘岩叨 | Skin nutritious agent |
| CN101167879B (en) * | 2007-11-08 | 2010-10-13 | 金城 | Preparation for increasing erection rigidity and prolonging intercourse endurance and condom containing the same |
| CN103705632A (en) * | 2013-12-27 | 2014-04-09 | 孟小斐 | Application of mammary aggregation dispersing tablets in preparation of medicines for treating penis hardening disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3256761B2 (en) | Treatment of symptoms and diseases | |
| AU773144B2 (en) | Drug preparations for treating sexual dysfunction | |
| JP4354528B2 (en) | Use of hyaluronic acid to treat interstitial cystitis | |
| US5583120A (en) | Hyaluronic acid-urea pharmaceutical compositions and uses | |
| DD202804A5 (en) | METHOD FOR PRODUCING A MEANS FOR THE PREVENTION AND TREATMENT OF LIVER AND KIDNEY DISEASES | |
| EP0971694B1 (en) | Drug preparations for treating sexual dysfunction | |
| CN1050502A (en) | The topical formulations of treatment aphthous ulcer and other infringement | |
| US5550112A (en) | Hyaluronic acid-urea pharmaceutical compositions and uses | |
| US6720011B1 (en) | Injectable composition for cancer treatment | |
| WO1994015623A9 (en) | Hyaluronic acid-urea pharmaceutical compositions and uses | |
| CN1903289A (en) | Gel for treating hemorrhoidal anus and rectum diseases, and its prepn. method | |
| CN1113757A (en) | Sexual function improving agent and its preparing method | |
| CN1075633A (en) | Liposomal piroxicam formulations | |
| Stewart et al. | The treatment of patients with interstitial cystitis, with special reference to intravesical DMSO | |
| US5576329A (en) | Method for treating tendon or joint inflammation with papaverine HCL | |
| JPH044300B2 (en) | ||
| US4552865A (en) | Psychotropic drugs | |
| CN1242785C (en) | Medication for treating ulcer of oral cavity and preparation method | |
| JPS58164516A (en) | Remedy for eczematoid skin disease and drug rash | |
| RU2071780C1 (en) | Method of treatment of medicinal esophago-gingivo-stomatitis | |
| CN1031037C (en) | Topically applied gold organic complex | |
| CN1399957A (en) | Application of shikonin and its derivative in pharmaceutical industry | |
| RU2351358C2 (en) | Application of lh for treatment of libido absence and achievement of orgasm | |
| EP1417969B1 (en) | A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application | |
| RU2196590C1 (en) | Agent carbon-mercury hydrosulfate complex and method of treatment of infectious inflammatory sicknesses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |